Cochlear is trading at 180.67 as of the 12th of February 2026. This is a 2.86 percent decrease since the beginning of the trading day. The stock's lowest day price was 180.67. Cochlear has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 14th of November 2025 and ending today, the 12th of February 2026. Click here to learn more.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 65.78 M outstanding shares. More on Cochlear Limited
Cochlear Limited [CHEOF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cochlear Limited classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 65.78 M outstanding shares.
Cochlear Limited has accumulated about 629.3 M in cash with 376.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.57.
Check Cochlear Probability Of BankruptcyOwnership AllocationCochlear holds a total of 65.78 Million outstanding shares. 30% of Cochlear Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cochlear Ownership Details
About 45.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 22nd of September 2022. Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.The quote for Cochlear Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Cochlear Limited please contact MBA BE at 61 2 9428 6555 or go to https://www.cochlear.com.
Cochlear Limited Investment Alerts
Cochlear Limited had very high historical volatility over the last 90 days
Cochlear Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Cochlear Profitablity
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.
Technical Drivers
As of the 12th of February 2026, Cochlear shows the mean deviation of 1.54, and Risk Adjusted Performance of 0.0198. Cochlear Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cochlear Limitedjensen alpha, and the relationship between the coefficient of variation and potential upside to decide if Cochlear Limited is priced correctly, providing market reflects its regular price of 180.67 per share. Given that Cochlear has jensen alpha of 0.1043, we suggest you to validate Cochlear Limited's prevailing market performance to make sure the company can sustain itself at a future point.
The output start index for this execution was zero with a total number of output elements of sixty-one. Cochlear Limited Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Cochlear price patterns.
Cochlear Predictive Daily Indicators
Cochlear intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cochlear pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cochlear's time-series forecasting models are one of many Cochlear's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cochlear's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Cochlear without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Economic Indicators Now
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Other Information on Investing in Cochlear Pink Sheet
Cochlear financial ratios help investors to determine whether Cochlear Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.